Evotec SE (EVO) Profit After Tax (2009 - 2025)
Evotec SE's (EVO) quarterly Profit After Tax came in at $120.6 million in Q4 2025, down 42.47% year-over-year from $209.7 million in Q4 2024, and up 239594.21% quarter-over-quarter from -$50371.1 in Q3 2025.
Analysis
Evotec SE (EVO) Profit After Tax (2009 - 2025) Analysis & Trends
Evotec SE has disclosed Profit After Tax across 9 years of filings, most recently posting $120.6 million for Q4 2025.
- In Q4 2025, Profit After Tax fell 42.47% year-over-year to $120.6 million; the TTM figure through Dec 2025 stood at $55.9 million (down 24.97% YoY), while the FY2025 annual figure was $117.0 million, down 44.89% from the prior year.
- Profit After Tax came in at $120.6 million for Q4 2025 at Evotec SE, up from -$50371.1 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $246.3 million in Q4 2021 to a low of -$112.6 million in Q2 2024.
- Average Profit After Tax over 5 years is $22.9 million, with a median of -$29810.4 recorded in 2022.
- Year-over-year, Profit After Tax surged 87633.05% in 2023 and tumbled 692844.61% in 2024.
- Over 5 years, Profit After Tax stood at $246.3 million in 2021, then slumped by 100.04% to -$103227.6 in 2022, then surged by 87633.05% to $90.4 million in 2023, then surged by 132.07% to $209.7 million in 2024, then plunged by 42.47% to $120.6 million in 2025.
- Per Business Quant data, the three most recent Profit After Tax figures were $120.6 million in Q4 2025, -$50371.1 in Q3 2025, and -$31.4 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.06 Bn | 42.11 Bn | 1.44 Bn | 258.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 121.36 Mn |
| 3 | Charles River Laboratories International | 13.77 Bn | 13.62 Bn | 452.07 Mn | -1.48 Mn |
| 4 | Icon | 12.62 Bn | 11.69 Bn | 479.29 Mn | 72.58 Mn |
| 5 | Fortrea Holdings | 1.68 Bn | 1.51 Bn | 139.20 Mn | -13.20 Mn |
| 6 | Evotec SE | 661.34 Mn | 235.46 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 442.79 Mn | 358.26 Mn | 18.44 Mn | -57.32 Mn |
| 8 | Champions Oncology | 72.49 Mn | 72.62 Mn | 7.03 Mn | -692,000.00 |
| 9 | MindWalk Holdings | 61.66 Mn | 53.38 Mn | 1.82 Mn | -3.09 Mn |
| 10 | VivoSim Labs | 1.47 Mn | 1.47 Mn | - | -1.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 120.64 Mn |
| Sep 30, 2025 | -50,371.08 |
| Jun 30, 2025 | -31.44 Mn |
| Mar 31, 2025 | -33.22 Mn |
| Dec 31, 2024 | 209.69 Mn |
| Sep 30, 2024 | -43,526.83 |
| Jun 30, 2024 | -112.65 Mn |
| Mar 31, 2024 | -22.46 Mn |
| Dec 31, 2023 | 90.36 Mn |
| Aug 29, 2023 | -31.38 Mn |
| Jun 30, 2023 | -16,256.55 |
| Dec 31, 2022 | -103,227.61 |
| Sep 30, 2022 | 47,666.17 |
| Jun 30, 2022 | -29,810.36 |
| Mar 31, 2022 | -82,202.26 |
| Dec 31, 2021 | 246.25 Mn |
| Sep 30, 2021 | 158,344.09 |
| Jun 30, 2021 | 72,274.35 |
| Mar 31, 2021 | 63,571.06 |
| Dec 31, 2020 | 511,492.35 |